-
CCK-8 Workflow for ER-Stressed Macrophages
2026-08-26
Use CCK-8 to quantify how tunicamycin, ER-stress inhibitors, or candidate compounds alter macrophage metabolic viability in a reproducible microplate workflow. The assay’s water-soluble formazan simplifies screening, while careful calibration and orthogonal death readouts prevent metabolic changes from being mistaken for cell-number changes.
-
Hydrocortisone Workflows for Rapid Cell Signaling
2026-08-25
Hydrocortisone supports controlled studies of glucocorticoid receptor signaling, acute neuronal calcium dynamics, barrier protection, and inflammation. This workflow-centered guide connects rapid live-cell assays with longer-term disease models while emphasizing solubility, timing, controls, and troubleshooting.
-
Go 6983 (pan-PKC inhibitor) Workflow Guide
2026-08-25
Build reproducible PKC pathway, EMT, cancer, and developmental-model assays with Go 6983 while separating acute signaling effects from long-term phenotypes. This guide combines formulation guidance, quantified pilot conditions, metabolism-aware readouts, and troubleshooting for more defensible mechanistic conclusions.
-
Pam3CSK4 TFA for TLR1/2 Immune Profiling
2026-08-24
Pam3CSK4 TFA enables controlled TLR1/2 agonism for dissecting cytokine competence rather than merely measuring inflammation. This article translates maternal–neonatal GBS findings into a rigorous assay strategy for mechanistic innate-immunity research.
-
PSA-CD56/Siglec-7 Immune Evasion in ccRCC
2026-08-24
A 2026 study identifies polysialylated CD56 as a glyco-immune checkpoint that engages Siglec-7 on CD8 T cells in clear cell renal cell carcinoma. The findings connect tumor-associated glycosylation with impaired cytokine production, T-cell apoptosis, immune exclusion, and resistance to immunotherapy, while supporting PSA-CD56 or Siglec-7 blockade as a mechanistically grounded intervention.
-
Cy5 TSA Fluorescence System Kit Guide
2026-08-22
A scenario-driven guide to using the Cy5 TSA Fluorescence System Kit, SKU K1052, for sensitive target detection in ICC, IHC, and FISH workflows. It explains HRP-mediated tyramide deposition, protocol parameters, controls, interpretation, and practical vendor-selection criteria for cell biology laboratories.
-
EZ Cap Cy5 Firefly Luciferase mRNA Workflow
2026-08-22
Track where an mRNA goes with Cy5, then measure what it produces with Firefly Luciferase in the same experiment. This dual-readout design helps separate delivery failure from translation failure during formulation screening, intracellular trafficking studies, and in vivo imaging development.
-
AptaBLE: Deep Learning for Aptamer Design
2026-08-21
AptaBLE is a sequence-based deep learning platform that combines pretrained protein and nucleic acid encoders with symmetric bidirectional cross-attention to predict aptamer–protein binding. The preprint reports improved binding-prediction performance and de novo aptamer generation with reported Kd values as low as 31 nM, while highlighting the need for experimental validation.
-
T. pallidum, ROS, and Hepatocyte Apoptosis
2026-08-20
The reference study identifies mitochondrial reactive oxygen species (ROS) accumulation as a central mechanism linking Treponema pallidum exposure to cardiolipin peroxidation, mitochondrial dysfunction, and intrinsic apoptosis in hepatocytes. Its dose-response design and ROS-inhibition experiments provide a mechanistic framework for studying syphilis-associated liver injury, while also highlighting the value of ATP and mitochondrial measurements as complementary functional readouts.
-
miR-3180 Rewires Lipid Metabolism in HCC
2026-08-20
Hong et al. identify miR-3180 as a coordinated regulator of fatty-acid synthesis and uptake in hepatocellular carcinoma, acting through SCD1 and CD36. The study links reduced miR-3180 expression with aggressive tumor behavior and poorer prognosis, while combining patient-tissue analysis, cellular assays, and xenograft validation to support a mechanistic model.
-
SN-38, FUBP1, and FUSE: A Mechanistic Study
2026-08-19
The reference study identifies SN-38, the active metabolite of irinotecan, as an inhibitor of the FUBP1–FUSE DNA interaction in addition to its established topoisomerase I activity. Its screening, biochemical, and cellular data suggest that disrupting FUBP1-dependent transcription may contribute to camptothecin and SN-38 activity in hepatocellular carcinoma, while also providing a testable framework for related cancer models.
-
Metal-Chelating l-Phe Nanostructures Sensitize ICB
2026-08-19
This Nature Nanotechnology study introduces metal-ion-chelating l-phenylalanine nanostructures that reprogram dendritic-cell electrophysiology and remodel immunosuppressive tumour microenvironments. By combining these structures with short-term starvation, the authors enhanced dendritic-cell maturation and tumour-specific cytotoxic T-cell responses, improving the rationale for combination immune checkpoint blockade.
-
BRD4–RAC1 Co-targeting in Breast Cancer
2026-08-18
The reference study shows that simultaneous inhibition of BRD4 and RAC1 suppresses breast-cancer growth, migration, stem-like traits, and xenograft tumorigenesis across molecular subtypes. Its mechanistic contribution is the connection of BRD4–RAC1 blockade to the c-MYC–G9a–FTH1 axis and HDAC1-associated chromatin regulation, providing a framework for evaluating combinatorial cancer epigenetics strategies.
-
BRD4–RAC1 Co-Targeting in Breast Cancer
2026-08-18
The reference study identifies combined BRD4 and RAC1 inhibition as a context-dependent strategy that suppresses growth, stemness, migration, and tumorigenesis across major breast cancer subtypes. Its mechanistic contribution is the connection of dual pathway inhibition to the c-MYC–G9a–FTH1 axis and HDAC1-associated chromatin regulation, providing a framework for interpreting combination treatments in heterogeneous breast cancer.
-
Annexin V-APC/7-AAD Apoptosis Kit Guide
2026-08-17
Build a rapid apoptosis and necrosis detection workflow for PAD4 inhibitor studies, tumor models, and immune-cell co-cultures. This guide explains how dual Annexin V-APC and 7-AAD staining distinguishes phosphatidylserine exposure from membrane failure, while highlighting controls, gating, and troubleshooting for reliable flow cytometry data.